Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,289 public trials 1,200 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Completed

A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer

NCT02897765

Conditions
Bladder Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +32 more
Locations
  • City of Hope Duarte, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

A Randomized Phase III Study of Palliative Radiation of Advanced Central Tumors With Intentional Avoidance of the Esophagus

NCT02752126

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Atlantic Clinical Cancer Centre Halifax, Nova Scotia, Canada
  • Grand River Regional Cancer Centre/Grand River Hospital Kitchener, Ontario, Canada
  • London Regional Cancer Program London, Ontario, Canada
View Trial Details
Completed

Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE)

NCT03061812

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +12 more
Locations
  • Clearview Cancer Institute /ID# 155873 Huntsville, Alabama, United States
  • Mitchell Cancer Institute /ID# 158151 Mobile, Alabama, United States
  • Carti /Id# 156982 Little Rock, Arkansas, United States
  • Highlands Oncology Group /ID# 155902 Springdale, Arkansas, United States
View all 195 locations
View Trial Details
Completed

Testing Afatinib in Combination With Pembrolizumab in Patients With Squamous Cell Carcinoma of the Lung

NCT03157089

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Baptist Health Medical Group Lexington, Kentucky, United States
  • HOP Côte de Nacre Caen, France
  • HOP Le Mans Le Mans, France
  • HOP Nord Marseille, France
View all 13 locations
View Trial Details
Completed

MEK162 for Patients With RAS/RAF/MEK Activated Tumors

NCT01885195

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
Locations
  • University of South Alabama / Mitchell Cancer Institute Univ South Alabama Mobile, Alabama, United States
  • Alaska Oncology and Hematology AOH (2) Anchorage, Alaska, United States
  • Arizona Oncology Associates AZ Oncology Assoc. Phoenix, Arizona, United States
  • Arizona Oncology Associates HOPE Division Phoenix, Arizona, United States
View all 68 locations
View Trial Details
Completed

Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)

NCT01327612

Conditions
Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +44 more
Locations
  • Research Site Duarte, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site Tampa, Florida, United States
View Trial Details
Completed

Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer

NCT00219297

Conditions
Brain Diseases, Brain Metastasis, Brain Neoplasms, +15 more
Locations
  • University of California Davis Cancer Center UC Davis Cancer (3) Sacramento, California, United States
  • Dana Farber Cancer Institute SC Boston, Massachusetts, United States
  • Wayne State University/Wertz Clinical Cancer Center Div. of Hematology/Oncology Detroit, Michigan, United States
  • St Louis University Cancer Center St Louis, Missouri, United States
View Trial Details
Completed

Phase II Safety and Efficacy Study of Crizotinib in East Asian Patients With ROS1 Positive, ALK Negative Advanced NSCLC

NCT01945021

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • The First Affiliated Hospital of Anhui Medical University, Department of Medical Oncology Hefei, Anhui, China
  • Department of Medical Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences Chaoyang District, Beijing Municipality, China
  • The Military General Hospital of Beijing PLA / Medical Oncology Dept. Dongcheng District, Beijing Municipality, China
  • 307 Hospital of PLA/Department of Lung Cancer Fengtai District, Beijing Municipality, China
View all 44 locations
View Trial Details

Related conditions